News Headlines Article

Headspace forms subsidiary to deliver prescription meditation app

Dive Brief:

  • Guided meditation platform Headspace announced the launch of Headspace Health, a digital medicine subsidiary aimed at delivering prescription meditation tools for physical ailments.
  • The new company expects to introduce its meditation app in 2020. Randomized clinical trials on an as-yet undisclosed disease state will begin this summer.
  • Headspace has conducted or completed more than 65 evidence-based research studies on the health effects of its meditation platform on conditions including cancer and asthma, and has plans to explore its use in sleep and pain management.

Dive Insight:
Among the organizations collaborating in its studies are Kaiser Permanente, Texas Health Science Center in San Antonio, Harvard University and the UK’s National Health Service. Joe Powers, a long-time veteran of the digital health space who last headed commercialization at John Hopkins inHealth, will serve as managing director of the new subsidiary.